🇺🇸 Morphine Sulfate Sustained-release Tablets in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 2
Most-reported reactions
- Platelet Count Decreased — 1 report (50%)
- Pneumonia — 1 report (50%)
Frequently asked questions
Is Morphine Sulfate Sustained-release Tablets approved in United States?
Morphine Sulfate Sustained-release Tablets does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Morphine Sulfate Sustained-release Tablets in United States?
Fujian Cancer Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.